92 related articles for article (PubMed ID: 24342414)
1. Coronary microvascular dysfunction portends poor prognosis in the setting of chronic renal failure: harnessing dual marker strategy for better risk-stratification?
Yalta K; Yilmaz MB
Int J Cardiol; 2014 Feb; 171(2):275-6. PubMed ID: 24342414
[No Abstract] [Full Text] [Related]
2. Methods to investigate coronary microvascular function in clinical practice.
Lanza GA; Camici PG; Galiuto L; Niccoli G; Pizzi C; Di Monaco A; Sestito A; Novo S; Piscione F; Tritto I; Ambrosio G; Bugiardini R; Crea F; Marzilli M;
J Cardiovasc Med (Hagerstown); 2013 Jan; 14(1):1-18. PubMed ID: 23222188
[TBL] [Abstract][Full Text] [Related]
3. Microvascular dysfunction in the spectrum of coronary instability.
De Caterina AR; Galiuto L; Fedele E; Crea F
Am J Cardiol; 2011 Nov; 108(10):1513-6. PubMed ID: 21871593
[TBL] [Abstract][Full Text] [Related]
4. Coronary microvascular dysfunction: sex-specific risk, diagnosis, and therapy.
Dean J; Cruz SD; Mehta PK; Merz CN
Nat Rev Cardiol; 2015 Jul; 12(7):406-14. PubMed ID: 26011377
[TBL] [Abstract][Full Text] [Related]
5. [New approaches in coronary microcirculation].
Ginghină C; Patriche M; Chreih R; Popescu BA; Deleanu D
Rev Med Chir Soc Med Nat Iasi; 2008; 112(3):711-8. PubMed ID: 20201258
[TBL] [Abstract][Full Text] [Related]
6. Coronary Microvascular Dysfunction Identifies Patients at High Risk of Adverse Events Across Cardiometabolic Diseases.
Osborne MT; Bajaj NS; Taqueti VR; Gupta A; Bravo PE; Hainer J; Bibbo CF; Dorbala S; Blankstein R; Di Carli MF
J Am Coll Cardiol; 2017 Dec; 70(22):2835-2837. PubMed ID: 29191335
[No Abstract] [Full Text] [Related]
7. [Cardiac alterations caused by renal failure].
Schannwell CM
Med Klin (Munich); 2006 Mar; 101 Suppl 1():69-71. PubMed ID: 16802524
[TBL] [Abstract][Full Text] [Related]
8. The Complex and Incomplete Relationship Between Exercise Stress Testing and Coronary Microvascular Dysfunction.
Miner SES; Blair JA; McCarthy MC; Nield LE
J Am Coll Cardiol; 2024 May; 83(20):e193-e194. PubMed ID: 38749627
[No Abstract] [Full Text] [Related]
9. Exercise Electrocardiographic Stress Test for Diagnosing Coronary Microvascular Dysfunction: Tale as Old as Time?
Dimitriadis K; Pyrpyris N; Tsioufis K
J Am Coll Cardiol; 2024 May; 83(20):e189. PubMed ID: 38749625
[No Abstract] [Full Text] [Related]
10. Cardiovascular assessment of diabetic end-stage renal disease patients before renal transplantation.
Welsh RC; Cockfield SM; Campbell P; Hervas-Malo M; Gyenes G; Dzavik V
Transplantation; 2011 Jan; 91(2):213-8. PubMed ID: 21048531
[TBL] [Abstract][Full Text] [Related]
11. Plasma granzyme B as a predicting factor of coronary artery disease--clinical significance in patients with chronic renal failure.
Ikemoto T; Hojo Y; Kondo H; Takahashi N; Hirose M; Nishimura Y; Katsuki T; Shimada K
J Cardiol; 2009 Dec; 54(3):409-15. PubMed ID: 19944316
[TBL] [Abstract][Full Text] [Related]
12. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
[TBL] [Abstract][Full Text] [Related]
13. Chronic renal dysfunction as an independent risk factor for the development of cardiovascular disease.
Varma R; Garrick R; McClung J; Frishman WH
Cardiol Rev; 2005; 13(2):98-107. PubMed ID: 15705261
[TBL] [Abstract][Full Text] [Related]
14. Relationship between coronary microcirculatory function and aortic stiffness in diabetes.
Nemes A
J Am Coll Cardiol; 2008 Feb; 51(5):597-8; author reply 598. PubMed ID: 18237692
[No Abstract] [Full Text] [Related]
15. Is assessment of peripheral endothelial dysfunction useful tool for risk stratification of type 2 diabetic patients with manifested coronary artery disease?
Bosevski M; Borozanov V; Tosev S; Georgievska-Ismail Lj
Int J Cardiol; 2009 Jan; 131(2):290-2. PubMed ID: 17964674
[TBL] [Abstract][Full Text] [Related]
16. Assessment and management of coronary artery disease in kidney and pancreas transplant candidates.
Knapper JT; Raval Z; Harinstein ME; Friedewald JJ; Skaro AI; Abecassis MI; Ali ZA; Gheorghiade M; Flaherty JD
J Cardiovasc Med (Hagerstown); 2019 Feb; 20(2):51-58. PubMed ID: 30540647
[TBL] [Abstract][Full Text] [Related]
17. Value of a new multiparametric score for prediction of microvascular obstruction lesions in ST-segment elevation myocardial infarction revascularized by percutaneous coronary intervention.
Amabile N; Jacquier A; Gaudart J; Sarran A; Shuaib A; Panuel M; Moulin G; Bartoli JM; Paganelli F
Arch Cardiovasc Dis; 2010 Oct; 103(10):512-21. PubMed ID: 21130964
[TBL] [Abstract][Full Text] [Related]
18. Microcirculatory dysfunction in the heart and the brain.
Mejía-Rentería H; Matias-Guiu JA; Lauri F; Yus M; Escaned J
Minerva Cardioangiol; 2019 Aug; 67(4):318-329. PubMed ID: 29687698
[TBL] [Abstract][Full Text] [Related]
19. Microcirculatory dysfunction in ST-elevation myocardial infarction: cause, consequence, or both?
Lerman A; Holmes DR; Herrmann J; Gersh BJ
Eur Heart J; 2007 Apr; 28(7):788-97. PubMed ID: 17347176
[TBL] [Abstract][Full Text] [Related]
20. Pathology of coronary microembolisation and no reflow.
Falk E; Thuesen L
Heart; 2003 Sep; 89(9):983-5. PubMed ID: 12923001
[No Abstract] [Full Text] [Related]
[Next] [New Search]
